Targeting cancer treatment for better outcomes
We welcome Kevin L. Schewe, a radiation oncologist, as we explore the evolution of cancer treatment from the perspective of someone who has witnessed groundbreaking advancements firsthand. From the significance of targeted therapies in improving patient outcomes to the transformative impact of cutting-edge technology like the radiation linear accelerator, Kevin sheds light on the intricacies of modern cancer care. We’ll also discuss the role of multidisciplinary teams, the importance of minimizing side effects, and the ethical considerations surrounding access to advanced treatments.
Kevin L. Schewe is a radiation oncologist.
He discusses the KevinMD article, “Evolution of targeted cancer therapies: a radiation oncologist’s perspective.”
Our presenting sponsor is Nuance, a Microsoft company.
Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care’s biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself.
The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows.
Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational.
Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo.
VISIT SPONSOR → https://nuance.com/daxinaction
SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
GET CME FOR THIS EPISODE → https://earnc.me/1T7xmH
Powered by CMEfy.
